Terms: = Kidney tumors AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Prognosis
28 results:
1. [Clinicopathological features of adult Wilms tumor with braf V600E mutation].
Gan HL; Wang QF; Zhu XL; Lyu H; Wang J
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1210-1215. PubMed ID: 38058036
[No Abstract] [Full Text] [Related]
2. Identification of braf, CCND1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
3. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
Kim SH; Park J; Park WS; Hong D; Chung J
Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
[TBL] [Abstract] [Full Text] [Related]
4. [Clinicopathological features and diagnosis of pericytic tumors of the kidney].
He YL; Zou YW; Hu YJ; Wu J; Zhang W; Yu WJ; Li YJ; Jiang YX
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):987-992. PubMed ID: 36207911
[No Abstract] [Full Text] [Related]
5. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract] [Full Text] [Related]
6. Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma.
Kim HM; Byun SS; Kim JK; Jeong CW; Kwak C; Hwang EC; Kang SH; Chung J; Kim YJ; Ha YS; Hong SH
BMC Med Inform Decis Mak; 2022 Sep; 22(1):241. PubMed ID: 36100881
[TBL] [Abstract] [Full Text] [Related]
7. SATB2 Expression in Human tumors: A Tissue Microarray Study on More Than 15 000 tumors.
Dum D; Kromm D; Lennartz M; De Wispelaere N; Büscheck F; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Minner S; Krech R; Bernreuther C; Marx A; Steurer S; Jacobsen F; Clauditz T; Krech T
Arch Pathol Lab Med; 2023 Apr; 147(4):451-464. PubMed ID: 35917493
[TBL] [Abstract] [Full Text] [Related]
8. Immune-Related LncRNAs as Prognostic Factors for Pediatric Rhabdoid Tumor of the kidney.
Hong Y; Que Y; Hu Y; Shi BY; Zhu J; Wang J; Huang JT; Sun FF; Zhang L; Zhou XK; Lu SY; Zhang YZ
Dis Markers; 2022; 2022():4752184. PubMed ID: 35756490
[TBL] [Abstract] [Full Text] [Related]
9. Sorafenib in Metastatic Papillary Thyroid Carcinoma with
Caterino M; Pirozzi M; Facchini S; Zotta A; Sica A; Lo Giudice G; Rauso R; Varriale E; Ciardiello F; Fasano M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630083
[TBL] [Abstract] [Full Text] [Related]
10. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
[TBL] [Abstract] [Full Text] [Related]
11. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K; Hes O; Williamson SR; Adeniran AJ; Agaimy A; Alaghehbandan R; Amin MB; Argani P; Chen YB; Cheng L; Epstein JI; Cheville JC; Comperat E; da Cunha IW; Gordetsky JB; Gupta S; He H; Hirsch MS; Humphrey PA; Kapur P; Kojima F; Lopez JI; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Menon S; Netto GJ; Przybycin CG; Rao P; Rao Q; Reuter VE; Saleeb RM; Shah RB; Smith SC; Tickoo S; Tretiakova MS; True L; Verkarre V; Wobker SE; Zhou M; Gill AJ
Mod Pathol; 2021 Jul; 34(7):1392-1424. PubMed ID: 33664427
[TBL] [Abstract] [Full Text] [Related]
12. Population-based estimates of survival among elderly patients with brain metastases.
Lamba N; Kearney RB; Catalano PJ; Hassett MJ; Wen PY; Haas-Kogan DA; Aizer AA
Neuro Oncol; 2021 Apr; 23(4):661-676. PubMed ID: 33068418
[TBL] [Abstract] [Full Text] [Related]
13. [Erdheim-Chester disease-A histiocytic multisystem disease with unusual renal involvement].
Dasdelen S; Büschek F
Internist (Berl); 2020 Sep; 61(9):969-979. PubMed ID: 32785740
[TBL] [Abstract] [Full Text] [Related]
14. braf V600E-mutated metastatic pediatric Wilms tumor with complete response to targeted RAF/MEK inhibition.
Obasaju P; Shahab S; Dunn E; Rhee DS; Jiang L; Dome JS; Friedman AD; Argani P; Pratilas CA
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238401
[TBL] [Abstract] [Full Text] [Related]
15. Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain Barrier.
Aasen SN; Espedal H; Holte CF; Keunen O; Karlsen TV; Tenstad O; Maherally Z; Miletic H; Hoang T; Eikeland AV; Baghirov H; Olberg DE; Pilkington GJ; Sarkar G; Jenkins RB; Sundstrøm T; Bjerkvig R; Thorsen F
Mol Cancer Ther; 2019 Nov; 18(11):2171-2181. PubMed ID: 31467182
[TBL] [Abstract] [Full Text] [Related]
16. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma.
Luo Y; Shen D; Chen L; Wang G; Liu X; Qian K; Xiao Y; Wang X; Ju L
Aging (Albany NY); 2019 Aug; 11(16):6029-6052. PubMed ID: 31422942
[TBL] [Abstract] [Full Text] [Related]
17. Copy Number Alterations with Prognostic Potential in Clear Cell Renal Cell Carcinoma.
Maruschke M; Koczan D; Ziems B; Hakenberg OW
Urol Int; 2018; 101(4):417-424. PubMed ID: 30227442
[TBL] [Abstract] [Full Text] [Related]
18. Decreased expression of braf-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
[TBL] [Abstract] [Full Text] [Related]
19. [Langerhans cell sarcoma: a clinicopathologic analysis of four cases].
Huang HJ; Chen XY; Zheng ZY
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):163-167. PubMed ID: 29534353
[No Abstract] [Full Text] [Related]
20. Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of braf and MEK inhibitors in the treatment of metastatic melanoma: A case report.
Maanaoui M; Saint-Jacques C; Gnemmi V; Frimat M; Lionet A; Hazzan M; Noël C; Provot F
Medicine (Baltimore); 2017 Jun; 96(25):e7196. PubMed ID: 28640105
[TBL] [Abstract] [Full Text] [Related]
[Next]
